Abstract: The present disclosure provides amino-substituted pyridazine compounds of formula (I), which are therapeutically useful as SMARCA2 and/or SMARCA4 degraders. These compounds are useful in the treatment and/or delaying progression of disease or disorder dependent upon SMARCA2 and/or SMARCA4 in a subject. The present disclosure also provides pharmaceutical compositions comprising at least one of the compounds of formula (I) or a pharmaceutically acceptable salt or a stereoisomer or a tautomer thereof.
| # | Name | Date |
|---|---|---|
| 1 | 202647066455-WIPO_PCT_DOC.pdf | 2026-05-27 |
| 2 | 202647066455-FORM-5 [27-05-2026(online)].pdf | 2026-05-27 |
| 3 | 202647066455-FORM 3 [27-05-2026(online)].pdf | 2026-05-27 |
| 4 | 202647066455-FORM 18 [27-05-2026(online)].pdf | 2026-05-27 |
| 5 | 202647066455-FORM 1 [27-05-2026(online)].pdf | 2026-05-27 |
| 6 | 202647066455-COMPLETE SPECIFICATION [27-05-2026(online)].pdf | 2026-05-27 |
| 7 | 202647066455-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [27-05-2026(online)].pdf | 2026-05-27 |
| 8 | 202647066455-Proof of Right [05-06-2026(online)].pdf | 2026-06-05 |
| 9 | 202647066455-PATENT_APPLICATION_PUBLICATION.pdf | 2026-06-06 |